Brief: Wuxi Biologics Posts H1 Net Income RMB 2,756.6 Million
19/08/2025 17:12
Aug 19 (Reuters) - WuXi Biologics (Cayman) Inc 2269.HK: H1 NET INCOME RMB 2,756.6 MILLION H1 REVENUE RMB 9,953.2 MILLION Further company coverage: 2269.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on WuXi Biologics (Cayman)
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
WuXi Biologics H1 net profit up on margin expansion
Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln